{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:20:44Z","timestamp":1790490044764,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["2012"],"award-info":[{"award-number":["2012"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s41416-019-0379-8","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:02:29Z","timestamp":1549843349000},"page":"387-397","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["MST1\/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial"],"prefix":"10.1038","volume":"120","author":[{"given":"Elodie","family":"Maille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solenn","family":"Brosseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Hanoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Creveuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Danel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Bergot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Scherpereel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Mazi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Margery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Greillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Audigier-Valette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Moro-Sibilot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Molinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Corre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Monnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Gounant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Langlais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7772-0581","authenticated-orcid":false,"given":"Gu\u00e9na\u00eblle","family":"Levallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Zalcman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"379_CR1","first-page":"260","volume":"17","author":"JC Wagner","year":"1960","unstructured":"Wagner, J. C., Sleggs, C. A. & Marchand, P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br. J. Ind. Med. 17, 260\u2013271 (1960).","journal-title":"Br. J. Ind. Med."},{"key":"379_CR2","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","volume":"387","author":"G Zalcman","year":"2016","unstructured":"Zalcman, G. et al. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial. Lancet 387, 1405\u20131414 (2016).","journal-title":"Lancet"},{"key":"379_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","volume":"48","author":"R Bueno","year":"2016","unstructured":"Bueno, R. et al. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat. Genet. 48, 407\u2013416 (2016).","journal-title":"Nat. Genet."},{"key":"379_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng, Z., Moroishi, T. & Guan, K.-L. Mechanisms of Hippo pathway regulation. Genes Dev. 30, 1\u201317 (2016).","journal-title":"Genes Dev."},{"key":"379_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2045-3701-3-31","volume":"3","author":"F Qin","year":"2013","unstructured":"Qin, F., Tian, J., Zhou, D. & Chen, L. Mst1 and Mst2 kinases: regulations and diseases. Cell Biosci. 3, 31 (2013).","journal-title":"Cell Biosci."},{"key":"379_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/srep45020","volume":"7","author":"A Bitra","year":"2017","unstructured":"Bitra, A., Sistla, S., Mariam, J., Malvi, H. & Anand, R. Rassf proteins as modulators of Mst1 kinase activity. Sci. Rep. 7, 45020 (2017).","journal-title":"Sci. Rep."},{"key":"379_CR7","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.1074\/jbc.M110.178210","volume":"286","author":"C Guo","year":"2011","unstructured":"Guo, C., Zhang, X. & Pfeifer, G. P. The tumour suppressor RASSF1A prevents dephosphorylation of the mammalian STE20-like kinases MST1 and MST2. J. Biol. Chem. 286, 6253\u20136261 (2011).","journal-title":"J. Biol. Chem."},{"key":"379_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cellsig.2017.05.005","volume":"36","author":"C Servas","year":"2017","unstructured":"Servas, C. et al. The mammalian STE20-like kinase 1 (MST1) is a substrate for the apoptosis inhibiting protein kinase CK2. Cell. Signal. 36, 163\u2013175 (2017).","journal-title":"Cell. Signal."},{"key":"379_CR9","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cub.2009.02.054","volume":"19","author":"S Chiba","year":"2009","unstructured":"Chiba, S., Ikeda, M., Katsunuma, K., Ohashi, K. & Mizuno, K. MST2- and Furry-mediated activation of NDR1 kinase is critical for precise alignment of mitotic chromosomes. Curr. Biol. 19, 675\u2013681 (2009).","journal-title":"Curr. Biol."},{"key":"379_CR10","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.cub.2007.02.055","volume":"17","author":"C Guo","year":"2007","unstructured":"Guo, C. et al. RASSF1A is part of a complex similar to the Drosophila Hippo\/Salvador\/Lats tumour-suppressor network. Curr. Biol. 17, 700\u2013705 (2007).","journal-title":"Curr. Biol."},{"key":"379_CR11","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.cub.2009.09.020","volume":"19","author":"A Hergovich","year":"2009","unstructured":"Hergovich, A. et al. The MST1 and hMOB1 tumour suppressors control human centrosome duplication by regulating NDR kinase phosphorylation. Curr. Biol.\n                           19, 1692\u20131702 (2009).","journal-title":"Curr. Biol."},{"key":"379_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cub.2008.02.006","volume":"18","author":"M Praskova","year":"2008","unstructured":"Praskova, M., Xia, F. & Avruch, J. MOBKL1A\/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr. Biol. 18, 311\u2013321 (2008).","journal-title":"Curr. Biol."},{"key":"379_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.scr.2017.02.011","volume":"20","author":"A Robertson","year":"2017","unstructured":"Robertson, A. et al. Genetic ablation of the mammalian sterile-20 like kinase 1 (Mst1) improves cell reprogramming efficiency and increases induced pluripotent stem cell proliferation and survival. Stem Cell Res. 20, 42\u201349 (2017).","journal-title":"Stem Cell Res."},{"key":"379_CR14","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/emboj.2009.82","volume":"28","author":"K Katagiri","year":"2009","unstructured":"Katagiri, K. et al. Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes. EMBO J. 28, 1319\u20131331 (2009).","journal-title":"EMBO J."},{"key":"379_CR15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/cr.2016.55","volume":"26","author":"Y Liang","year":"2016","unstructured":"Liang, Y. et al. Long-term in vivo single-cell tracking reveals the switch of migration patterns in adult-born juxtaglomerular cells of the mouse olfactory bulb. Cell Res. 26, 805\u2013821 (2016).","journal-title":"Cell Res."},{"key":"379_CR16","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.4049\/jimmunol.1600874","volume":"197","author":"X Xu","year":"2016","unstructured":"Xu, X. et al. Mst1 kinase regulates the actin-bundling protein L-plastin to promote T cell migration. J. Immunol. 197, 1683\u20131691 (2016).","journal-title":"J. Immunol."},{"key":"379_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.lungcan.2006.06.017","volume":"54","author":"JR Fischer","year":"2006","unstructured":"Fischer, J. R. et al. Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma. Lung Cancer 54, 109\u2013116 (2006).","journal-title":"Lung Cancer"},{"key":"379_CR18","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1038\/sj.onc.1205381","volume":"21","author":"S Toyooka","year":"2002","unstructured":"Toyooka, S. et al. Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells. Oncogene 21, 4340\u20134344 (2002).","journal-title":"Oncogene"},{"key":"379_CR19","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1158\/1078-0432.CCR-11-2797","volume":"18","author":"F Fraipont de","year":"2012","unstructured":"de Fraipont, F. et al. An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial. Clin. Cancer Res. 18, 2976\u20132986 (2012).","journal-title":"Clin. Cancer Res."},{"key":"379_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/mc.20317","volume":"46","author":"C Seidel","year":"2007","unstructured":"Seidel, C. et al. Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma. Mol. Carcinog. 46, 865\u2013871 (2007).","journal-title":"Mol. Carcinog."},{"key":"379_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/JTO.0b013e3182417da5","volume":"7","author":"G Levallet","year":"2012","unstructured":"Levallet, G. et al. Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH Group. J. Thorac. Oncol. 7, 599\u2013606 (2012).","journal-title":"J. Thorac. Oncol."},{"key":"379_CR22","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1158\/0008-5472.CAN-15-1008","volume":"76","author":"F Dubois","year":"2016","unstructured":"Dubois, F. et al. RASSF1A suppresses the invasion and metastatic potential of human non-small cell lung cancer cells by inhibiting YAP activation through the GEF-H1\/RhoB pathway. Cancer Res. 76, 1627\u20131640 (2016).","journal-title":"Cancer Res."},{"key":"379_CR23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/JTO.0000000000000493","volume":"10","author":"A Miyanaga","year":"2015","unstructured":"Miyanaga, A. et al. Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing. J. Thorac. Oncol. 10, 844\u2013851 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"379_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.21037\/tlcr.2017.06.02","volume":"6","author":"GA Woodard","year":"2017","unstructured":"Woodard, G. A., Yang, Y.-L., You, L. & Jablons, D. M. Drug development against the hippo pathway in mesothelioma. Transl. Lung Cancer Res. 6, 335\u2013342 (2017).","journal-title":"Transl. Lung Cancer Res."},{"key":"379_CR25","first-page":"1519","volume":"22","author":"K Steinmann","year":"2009","unstructured":"Steinmann, K., Sandner, A., Schagdarsurengin, U. & Dammann, R. H. Frequent promoter hypermethylation of tumour-related genes in head and neck squamous cell carcinoma. Oncol. Rep. 22, 1519\u20131526 (2009).","journal-title":"Oncol. Rep."},{"key":"379_CR26","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.bbrc.2015.06.043","volume":"463","author":"T Fukuhara","year":"2015","unstructured":"Fukuhara, T. et al. Hypermethylation of MST1 in IgG4-related autoimmune pancreatitis and rheumatoid arthritis. Biochem. Biophys. Res. Commun. 463, 968\u2013974 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"379_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1440-1827.2011.02666.x","volume":"61","author":"Y Sekido","year":"2011","unstructured":"Sekido, Y. Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation: Merlin inactivation in mesothelioma. Pathol. Int. 61, 331\u2013344 (2011).","journal-title":"Pathol. Int."},{"key":"379_CR28","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1158\/1078-0432.CCR-16-1971","volume":"23","author":"R Tranchant","year":"2017","unstructured":"Tranchant, R. et al. Co-occurring mutations of tumour suppressor genes, LATS2 and NF2, in malignant pleural mesothelioma. Clin. Cancer Res. 23, 3191\u20133202 (2017).","journal-title":"Clin. Cancer Res."},{"key":"379_CR29","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1007\/s13277-013-0895-8","volume":"34","author":"X Lin","year":"2013","unstructured":"Lin, X. et al. Prognostic significance of mammalian sterile 20-like kinase 1 in breast cancer. Tumour Biol. 34, 3239\u20133243 (2013).","journal-title":"Tumour Biol."},{"key":"379_CR30","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1158\/1078-0432.CCR-15-1447","volume":"22","author":"BH Sohn","year":"2016","unstructured":"Sohn, B. H. et al. Inactivation of Hippo pathway is significantly associated with poor prognosis in hepatocellular carcinoma. Clin. Cancer Res. 22, 1256\u20131264 (2016).","journal-title":"Clin. Cancer Res."},{"key":"379_CR31","doi-asserted-by":"publisher","first-page":"14265","DOI":"10.1038\/s41598-017-14539-x","volume":"7","author":"J Yu","year":"2017","unstructured":"Yu, J. Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach. Sci. Rep. 7, 14265 (2017).","journal-title":"Sci. Rep."},{"key":"379_CR32","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3892\/ijo.2014.2447","volume":"45","author":"S Attarha","year":"2014","unstructured":"Attarha, S., Andersson, S., Mints, M. & Souchelnytskyi, S. Mammalian sterile-like 1 kinase inhibits TGF\u03b2 and EGF\u2010dependent regulation of invasiveness, migration and proliferation of HEC-1-A endometrial cancer cells. Int. J. Oncol. 45, 853\u2013860 (2014).","journal-title":"Int. J. Oncol."},{"key":"379_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/genes7060028","volume":"7","author":"E Fallahi","year":"2016","unstructured":"Fallahi, E., O\u2019Driscoll, N. & Matallanas, D. The MST\/Hippo pathway and cell death: a non-canonical affair. Genes 7, 28 (2016).","journal-title":"Genes"},{"key":"379_CR34","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1021\/acs.biochem.6b00763","volume":"55","author":"JA Galan","year":"2016","unstructured":"Galan, J. A. & Avruch, J. MST1\/MST2 protein kinases: regulation and physiologic roles. Biochemistry 55, 5507\u20135519 (2016).","journal-title":"Biochemistry"},{"key":"379_CR35","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1158\/0008-5472.CAN-05-2951","volume":"66","author":"HJ Oh","year":"2006","unstructured":"Oh, H. J. et al. Role of the tumour suppressor RASSF1A in Mst1-mediated apoptosis. Cancer Res. 66, 2562\u20132569 (2006).","journal-title":"Cancer Res."},{"key":"379_CR36","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/abbs\/gmt006","volume":"45","author":"C Xu","year":"2013","unstructured":"Xu, C., Liu, C., Huang, W., Tu, S. & Wan, F. Effect of Mst1 overexpression on the growth of human hepatocellular carcinoma HepG2 cells and the sensitivity to cisplatin in vitro. Acta Biochim. Biophys. Sin. 45, 268\u2013279 (2013).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"379_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/cgt.2013.40","volume":"20","author":"CM Xu","year":"2013","unstructured":"Xu, C. M. et al. Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo. Cancer Gene Ther. 20, 453\u2013460 (2013).","journal-title":"Cancer Gene Ther."},{"key":"379_CR38","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1111\/jcmm.13182","volume":"21","author":"WQ Zhang","year":"2017","unstructured":"Zhang, W.-Q. et al. Targeting YAP in malignant pleural mesothelioma. J. Cell. Mol. Med. 21, 2663\u20132676 (2017).","journal-title":"J. Cell. Mol. Med."},{"key":"379_CR39","first-page":"27","volume":"6","author":"C Wang","year":"2015","unstructured":"Wang, C. et al. Verteporfin inhibits YAP function through up-regulating 14-3-3\u03c3 sequestering YAP in the cytoplasm. Am. J. Cancer Res. 6, 27\u201337 (2015).","journal-title":"Am. J. Cancer Res."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0379-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0379-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0379-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:04:11Z","timestamp":1684616651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-019-0379-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["379"],"URL":"https:\/\/doi.org\/10.1038\/s41416-019-0379-8","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"5 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All data are stored at the IFCT centre and can be made available upon request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Specific informed consent was obtained for the biological studies (Bio-MAPS), and the trial was approved by the appropriate ethics committee (CPP Ref 2007-20 Nord-Ouest III, France).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Note"}}]}}